Phenotypic Spectrum at Diagnosis of Age‐Related Endotypes of Type 1 Diabetes Mellitus: A Cross‐Sectional Study in China

Qiaoli Zhou, Zheng Xueqin, Chenguang Ma, Wei GuJournal of Diabetes 2025 · DOI

TL;DR

This study reveals significant age-related differences in how Type 1 Diabetes Mellitus (T1DM) presents in children, suggesting distinct "endotypes" that could inform personalized treatment strategies. By analyzing a large cohort of Chinese children, researchers found that younger children (<7 years) and older children (≥13 years) exhibit unique patterns in their metabolic function, immune markers, and other clinical characteristics at diagnosis.

What Problem Does This Paper Address?

Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells. While T1DM is generally understood as a single disease, emerging evidence points to significant heterogeneity, with distinct "endotypes" potentially existing. This heterogeneity complicates diagnosis and treatment, as a one-size-fits-all approach may not be optimal. Previous research has hinted at age-related differences, with two proposed endotypes (T1DE1 for early onset and T1DE2 for later onset) based on limited histopathological data. However, a comprehensive understanding of the phenotypic spectrum across different age groups, particularly in non-Caucasian populations, and its implications for clinical presentation at diagnosis, has been lacking. This paper aims to fill that gap by thoroughly characterizing the phenotypic variations in pediatric T1DM based on age at diagnosis in a Chinese cohort.

Methods

This study employed a cross-sectional design, analyzing data from 1204 children newly diagnosed with T1DM at a tertiary hospital in Nanjing, China, between January 1, 2010, and December 31, 2023. Patients were categorized into three age groups: <7 years (T1DE1), 7-12 years, and ≥13 years (T1DE2). The researchers collected and compared a wide range of data at the time of diagnosis, including:

  • Demographic characteristics: Age, sex, season of diagnosis/birth, duration of symptoms.
  • Glucose metabolism: Fasting and 2-hour serum glucose, C-peptide, and C-peptide to glucose ratio (CGR).
  • ẞ-cell autoimmunity: Levels of various autoantibodies, including GADA, IAA, ICA, IA2A, and ZnT8.
  • Metabolic decompensation: Presence of diabetic ketosis (DK) and diabetic ketoacidosis (DKA), pH, bicarbonate, beta-hydroxybutyrate, and ketonuria.
  • Thyroid function: TPOAb and TgAb positivity, and TSH levels.
  • Liver function: ALT, AST, and ALP levels.
  • Other markers: Creatine kinase-MB (CK-MB).

Statistical analyses included Pearson's chi-square tests for categorical variables and Kruskal-Wallis tests for continuous variables, with post hoc pairwise comparisons and corrections for multiple testing.

Datasets

The study utilized a retrospective dataset of 1204 children newly diagnosed with T1DM from the Endocrinology Department of Children's Hospital of Nanjing Medical University. This dataset was collected between January 1, 2010, and December 31, 2023. No new benchmarks were introduced; the study focused on analyzing existing clinical data.

Key Insights and Ideas

  • Age as a Primary Driver of Phenotypic Heterogeneity: The study strongly supports the idea that age at diagnosis is a critical factor shaping the presentation of T1DM, suggesting distinct endotypes. This moves beyond a single disease model to a more nuanced understanding.
  • Younger Children (<7 years) Show Signs of More Aggressive Disease at Onset: These children had shorter symptom durations, lower residual B-cell function (indicated by lower C-peptide and CGR), and higher postprandial glucose. This suggests a more rapid and severe onset in this group.
  • Older Children (≥13 years) Exhibit Different Autoimmune and Metabolic Signatures: This group presented with higher HbA1c levels and a greater prevalence of certain autoantibodies (GADA, TPOAb, TgAb), along with more frequent abnormal liver function. This points to a potentially different underlying autoimmune process or a longer duration of subclinical disease.
  • Specific Autoantibody Patterns Align with Age Groups: The study observed distinct patterns in autoantibody positivity, with younger children showing higher IAA positivity and older children showing higher GADA positivity, aligning with proposed endotype characteristics.
  • Implications for Treatment: The identified age-specific phenotypic differences are crucial because they may predict differential responses to therapies. For instance, T1DE1 might benefit more from immunotherapies targeting specific immune cells, while T1DE2 might respond better to GAD-alum therapy.

Key Results

  • Symptom Duration: Patients <7 years had the shortest symptom duration before diagnosis.
  • B-cell Function: Patients <7 years had significantly lower fasting and 2-h C-peptide and CGR compared to older groups.
  • Glucose Metabolism: Patients <7 years had the highest postprandial glucose levels.
  • Autoimmunity: Patients <7 years had the lowest GADA positivity rate and the highest IAA positivity rate. Patients ≥13 years had the highest GADA positivity rate.
  • Thyroid and Liver Function: The prevalence of TPOAb, TgAb positivity, and abnormal liver function (ALT, ALP) increased with age.
  • HbA1c: Patients <7 years had the lowest HbA1c levels (11.69% ±2.08%), significantly lower than the other age groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Single-Center Study: The findings may not be generalizable to other populations due to the single-center nature of the study.
  • Cross-Sectional Design: The study could not analyze treatment responses or long-term prognosis, as data was collected only at diagnosis.
  • Age Group Sample Size: The ≥13 years age group had a smaller sample size, potentially limiting the power of some analyses.

Future work should focus on:

  • Longitudinal Studies: Analyzing follow-up data to understand treatment responses and long-term prognosis for each endotype.
  • Causation: Investigating the causal links between age-related factors, immune responses, and disease progression.
  • Broader Population Studies: Expanding research to diverse ethnic groups to confirm or refute the generalizability of these endotypes.
  • Exploring Other Endotypes: Investigating the existence and characteristics of other proposed T1DM endotypes (T1DE3-6).

Summary updated

Abstract

The study illustrates age-specific phenotypic heterogeneity in pediatric T1DM, indicating the presence of distinct endotypes. Further investigation of these endotypes may offer more evidence for the precise treatment of T1DM.
BibTeX
@article{zhou2025phenotypic,
  author = {Qiaoli Zhou and Zheng Xueqin and Chenguang Ma and Wei Gu},
  title = {{Phenotypic Spectrum at Diagnosis of Age‐Related Endotypes of Type 1 Diabetes Mellitus: A Cross‐Sectional Study in China}},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70111},
}
Figure